Completed
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
NCT00886353
- Conditions
- Cancer Diseases, Cardiovascular Diseases, Female Urogenital Diseases, +8 more
- Locations
-
- University Hospital Basel Basel, Switzerland